(PharmaNewsWire.Com, December 02, 2021 ) Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.
According to a new market research report “Transfer Membrane Market by Type (PVDF, Nitrocellulose, Nylon), Transfer Method (Tank, Semi-dry, Dry), Application (Western, Northern, Southern Blot, Protein Sequencing), End user (Academia, Diagnolab, Pharmaceutical Companies) – Global Forecast to 2023“, published by MarketsandMarkets™, the global market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.
Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are driving the growth of this market.
By Type, the PVDF transfer membrane segment is expected to hold the largest share of the market in 2018
On the basis of types, the Transfer Membrane Market is classified into nylon transfer membrane, nitrocellulose transfer membrane, and PVDF transfer membranes. In 2018, PVDF transfer membranes are expected to command the major share of the Transfer Membrane Market.. The PVDF transfer membrane segment is expected to account for the largest share of the Transfer Membrane Market in 2018. Advantages of PVDF transfer membrane over nitrocellulose membranes such as higher durability and hydrophobicity, increasing R&D by pharmaceutical and biotechnology companies, and growing proteomic research are the major factors driving the growth of this segment.
By Transfer method, the dry electro transfer segment is expected to be the fastest growing segment in the forecast period
On the basis of transfer method, the Transfer Membrane Market is segmented into tank electrotransfer, semi-dry electrotransfer, dry electrotransfer, and other transfer methods (diffusion blotting and vacuum blotting). The Dry electrotransfer segment is expected to grow at the fastest CAGR during the forecast period. Growth in this segment is attributed to the advantages of dry-electrotransfer over conventional methods, including rapid, high-quality transfer and ease of use due to the non-requirement of additional buffers in the case of dry-electroblotting.
North America is expected to dominate the market in 2018
Geographically, the Transfer Membrane Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2018, followed by Europe. The large share of North America can primarily be attributed to presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and a high disease prevalence in the region.
The key players in the Transfer Membrane Market include Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India), among others.
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Browse Related Reports:
Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) – Global Forecasts to 2021
Membranes Market by Material (Polymeric, Ceramic), Technology (RO, UF, MF, NF), Application (Water & Wastewater Treatment, Industrial Processing), Region (North America, APAC, Europe, MEA, South America) – Global Forecast to 2024
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: